Kaposi's sarcoma epidemiology and demographics: Difference between revisions
(Created page with "{{CMG}} {{Kaposi's sarcoma}} ==Overview== ==Epidemiological Varieties== '''Classic KS''' As originally described was a relatively indolent disease affecting elderly men from...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Kaposi's sarcoma}} | |||
{{CMG}} | {{CMG}} | ||
Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing. | |||
==Overview== | ==Overview== | ||
| Line 22: | Line 25: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
[[Category:Disease]] | |||
[[Category:HIV/AIDS]] | |||
[[Category:Types of cancer]] | |||
[[Category:Oncology]] | |||
[[Category:Dermatology]] | |||
[[Category:Pulmonology]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Infectious disease]] | |||
[[Category:Mature chapter]] | |||
Revision as of 19:08, 12 September 2012
|
Kaposi's sarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Kaposi's sarcoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Kaposi's sarcoma epidemiology and demographics |
|
Risk calculators and risk factors for Kaposi's sarcoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Epidemiological Varieties
Classic KS As originally described was a relatively indolent disease affecting elderly men from the Mediterranean region, or of Eastern European Jewish descent.[1][2]
Endemic KS Was described later in young African people, mainly from sub-Saharan Africa, as a more aggressive disease which infiltrated the skin extensively, especially on the lower limbs. This, it should be noted, is unrelated to HIV infection.[3][4]
Transplant Related KS Had been described, but only rarely until the advent of calcineurin inhibitors (such as ciclosporin, which are inhibitors of T-cell function) for transplant patients in the 1980s, when its incidence grew rapidly.[5][6]
Epidemic KS Was described during the 1980s as an aggressive disease in AIDS patients (HIV also causes a defect in T-cell immunity). It is over 300 times more common in AIDS patients than in renal transplant recipients. [7]
Note that HHV-8 is responsible for all varieties of KS.
Demographics
References
- ↑ Iscovich, J (1998). "Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study". AIDS. 12 (15): 2067–72. Unknown parameter
|month=ignored (help) - ↑ Fenig, E (1998). "Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel". Am J Clin Oncol. 21 (5): 498–500. Unknown parameter
|month=ignored (help) - ↑ Cook-Mozaffari, P (1998). "The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic". Br J Cancer. 78 (11): 1521–8. Unknown parameter
|month=ignored (help) - ↑ Olsen, SJ (1998). "Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985" (PDF). AIDS. 12 (14): 1921–5. Unknown parameter
|month=ignored (help) - ↑ Qunibi, W (1998). "Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia". Transplantation. 65 (4): 583–5. Unknown parameter
|month=ignored (help) - ↑ Luppi, Mario (2000). "Bone marrow failure associated with human herpesvirus 8 infection after transplantation". N Engl J Med. 343 (19): 1378–85. Unknown parameter
|month=ignored (help) - ↑ Beral, V (1990). "Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?". Lancet. 335 (8682): 123–8. Unknown parameter
|month=ignored (help)